Cusabio Technology LLC

Join us on December 11, 2024, for a webinar discussing the latest research progress in cell therapy, with a focus on ongoing studies that examine both the benefits and limitations of expanding CAR-T therapy. This promising approach represents a pivotal shift toward more targeted and effective treatments, positioning CAR-T cell therapy as a powerful tool in the fight against cancer and other diseases. ?? Register here: https://bit.ly/48PpLLE

In this webinar, we will discuss the research progress in cell therapy, with a focus on ongoing studies that explore both the benefits and limitations of expanding CAR-T therapy. This promising development marks a pivotal shift toward more targeted and effective treatments, positioning CAR-T cell therapy as a powerful ally in the fight against cancer and other diseases. Learn more: https://bit.ly/48PpLLE

?? Thanksgiving Research Feast – Special Offers Just for You ?? This Thanksgiving, we’re especially thankful for the researchers who choose us as their trusted partner. ?? To show our appreciation, enjoy these deals: ?? 24T ELISA Trial Size - Only $150/kit ?? https://lnkd.in/gyGBMqJJ ?? CUSABIO Research Sponsorship Plan ?? https://lnkd.in/gyHrJS5n ?? 20% OFF All In-Stock Recombinant Antibodies ?? https://lnkd.in/gN_uFswT ?? 20 μg Antibody Trial – Get One Sample for Free ?? https://lnkd.in/dKipWNtx ?? Free Trial – Anti-Payload Antibodies ?? https://lnkd.in/gQ5nUxEZ ?? Free Trial – Anti-CAR Linker Antibodies ?? https://lnkd.in/gPTD4E2s #ThanksgivingResearchFeast #ResearchDiscounts #ELISAKits #RecombinantAntibodies #FreeSamples #HappyThanksgiving

This study reveals how IRE1α interacts with stress granules (SGs) to strengthen cellular resilience during ER stress. Through ER membrane-bound phase separation, IRE1α forms clusters that tether to SGs via intrinsically disordered regions, amplifying the pro-survival IRE1α–XBP1 pathway for efficient UPR activation. Disruption of SG assembly impairs IRE1α clustering and reduces stress-handling capacity, underscoring the vital role of IRE1α–SG coalescence in preserving cellular homeostasis. ?? Learn more: https://lnkd.in/gYBMiDBz

Desmoglein 3 (Dsg3) is a key adhesion protein in epithelial cells, forming desmosomes through interactions with proteins like Dsg1 and Dsc2/3. It plays a vital role in maintaining tissue stability in the skin and mucosa. Dysfunction of Dsg3 is linked to diseases like Pemphigus Vulgaris, making it a critical research target. CUSABIO offers high-quality Dsg3 reagents, validated for diverse applications, with dependable technical support. ?? Learn more: https://bit.ly/3VvkZxt #Dsg3 #CellAdhesion #SkinBiology #CUSABIO

In September 2024, Daiichi Sankyo shared exciting Phase I trial results for DS-9606, an ADC targeting Claudin-6 (CLDN6). The trial showed good clinical activity and tolerability in advanced solid tumors expressing CLDN6, with no dose-limiting toxicities. Notably, tumor responses were confirmed in four patients at doses ≥0.072 mg/kg. With CLDN6 emerging as a key target in cancer therapy, DS-9606 offers new hope for advanced solid tumor treatment. ?? Read more: https://bit.ly/3ZbJ3Xc #CancerResearch #ADC #Oncology #CLDN6

GUCY2C, a transmembrane protein regulating intestinal function, is highly overexpressed in colorectal cancer—2–10 times higher in metastatic cells compared to normal ones. It’s also prevalent in pancreatic, gastric, and esophageal cancers, making it a promising target for cancer diagnosis and therapy. Learn more: https://bit.ly/4g3Icyw

Pancreatic cancer is mainly divided into exocrine tumors (95%) and rare endocrine tumors. Early symptoms like vague abdominal pain and fatigue are often overlooked, highlighting the importance of early diagnosis. To support your research, CUSABIO offers a curated list of popular targets and related products for pancreatic cancer mechanism studies and drug development. ?? Learn more: https://bit.ly/3ZhdbkR

A study from Kanazawa University last year revealed a new role for osteopontin in HCV-related hepatocellular carcinoma. The study identified CD44 as a prevalent marker for cancer stem cells (CSCs) across multiple cancers, making it a key focus in cancer therapy research. This article integrates various studies and data to explore CD44 from the following perspectives: https://bit.ly/3O7COyv

With CUSABIO ELISA Kits for Food Safety & Drug Residues researchers and labs can reliably detect antibiotic residues like chloramphenicol and tetracyclines, supporting food safety and antibiotic resistance studies. Learn more about our residue detection tools ?? https://bit.ly/4ey27EH #EuropeanAntibioticAwarenessDay #AntibioticResidues #FoodSafety #CUSABIO